Prices delayed by 15 minutes
Next earnings report: 29 October 2026 · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
ResMed Inc. trades on NYSE under the ticker RMD. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks RMD has traded between 180.27 $ and 284.87 $. As of 09 October 2026 the price stood 44.42 % of the way from the 52-week low to the high.
Over one year RMD shares fell 19.96 %; over six months they fell 0.55 %. Volatility over 90 days is 33.29 %. Dividends are not included: this is price change only, as of 09 October 2026.
RMD trades at a price-to-earnings ratio of 21.6, below the sector median of 24.8. Price to sales is 5.9, above the sector median of 3.9. Price to book is 5.0, above the sector median of 2.4. Calculated from reports for the period ending 31 March 2026.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 08 October 2026 | 225.79 | 226.88 | 223.04 | 226.73 | 651,100 |
| 07 October 2026 | 222.27 | 228.75 | 221.83 | 225.98 | 1M |
| 06 October 2026 | 223.90 | 225.23 | 219.96 | 220.69 | 972,600 |
| 05 October 2026 | 218.44 | 223.72 |
Based on the last 12 months of reports, through 31 March 2026
The sector median covers every company in the sector on the US market, loss-making ones included.
ResMed makes machines and masks for treating sleep apnoea — breathing interruptions the patient usually does not suspect.
The machine delivers pressurised air and lasts for years, while masks, tubing and filters are replaced regularly — hence recurring revenue that grows with the installed base. Only a minority of those who have the condition are diagnosed, and that sets a long horizon for the market's growth.
The company pairs the hardware with software that tracks whether the patient actually uses the machine: both the treatment outcome and the insurer's payment depend on it. A separate story of recent years is weight-loss drugs: the market feared that weight loss would shrink the patient pool, whereas the data so far shows the opposite. ResMed pays a dividend.
Address:9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA, 92123, US
ResMed Inc. reported revenue of 5.5B $ and net income of 1.5B $ over the last four quarters. Net margin is 27.44 %. Revenue changed by +10.28 % year over year. Earnings per share are 10.37 $. Market capitalisation is 32.8B $.
RMD has a return on equity of 23.41 %, above the sector median of −41.68 %. Return on assets is 17.30 %, above the sector median of −32.11 %. Operating margin is 34.18 %, above the sector median of −26.84 %.
| 325M |
| DXCMDexCom, Inc. | 84.15 | −0.31 % | 324M |
| MDLNMedline Inc. | 36.26 | +1.45 % | 297M |
| PODDInsulet Corporation | 135.28 | +0.60 % | 244M |
| WSTWest Pharmaceutical Services, Inc. | 368.78 | +1.52 % | 207M |
| 218.44 |
| 222.86 |
| 976,500 |
| 02 October 2026 | 221.66 | 223.73 | 218.03 | 218.89 | 898,900 |
| 01 October 2026 | 220.75 | 224.14 | 219.00 | 221.15 | 930,400 |
| 30 September 2026 | 222.63 | 224.04 | 220.00 | 221.10 | 1M |
| 29 September 2026 | 221.96 | 224.22 | 220.32 | 222.83 | 949,400 |
| 28 September 2026 | 221.52 | 223.00 | 218.26 | 222.10 | 862,800 |
| 25 September 2026 | 221.08 | 223.22 | 220.13 | 222.00 | 760,800 |
| 24 September 2026 | 223.08 | 224.50 | 220.39 | 221.89 | 798,800 |
| 23 September 2026 | 222.78 | 225.10 | 220.00 | 222.30 | 1M |
| 22 September 2026 | 226.22 | 227.90 | 221.82 | 221.97 | 1M |
| 21 September 2026 | 225.16 | 226.52 | 223.34 | 223.61 | 1M |
| 18 September 2026 | 228.21 | 228.39 | 224.56 | 224.99 | 4M |
| 17 September 2026 | 228.25 | 229.57 | 225.08 | 228.42 | 1M |
| 16 September 2026 | 228.19 | 229.33 | 224.26 | 228.25 | 1M |
| 15 September 2026 | 226.36 | 234.33 | 225.12 | 229.44 | 2M |
| 14 September 2026 | 221.04 | 225.82 | 220.94 | 222.99 | 989,000 |
| 11 September 2026 | 220.44 | 221.29 | 215.97 | 218.27 | 912,300 |